Ignite Creation Date:
2024-05-06 @ 3:12 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04555486
Status:
COMPLETED
Last Update Posted:
2024-07-11
First Post:
2020-09-02
Brief Title:
Study to Evaluate Safety Tolerability PK and PD of DCR-PHXC in PH Type 3 Patients
Sponsor:
Dicerna Pharmaceuticals Inc a Novo Nordisk company
Organization:
Novo Nordisk AS
Organization Data
Organization:
Novo Nordisk AS
Class:
INDUSTRY
Study ID:
DCR-PHXC-104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dicerna Pharmaceuticals Inc a Novo Nordisk company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None